The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(2-(5-fluoro-2-(1-(2-fluorobenzyl)-5-(isoxazol-3-yl)-1H-pyrazol-3-yl)pyrimidin-4-yloxy)ethyl)morpholine ID: ALA4845811
PubChem CID: 118965719
Max Phase: Preclinical
Molecular Formula: C23H22F2N6O3
Molecular Weight: 468.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Fc1ccccc1Cn1nc(-c2ncc(F)c(OCCN3CCOCC3)n2)cc1-c1ccon1
Standard InChI: InChI=1S/C23H22F2N6O3/c24-17-4-2-1-3-16(17)15-31-21(19-5-9-34-29-19)13-20(28-31)22-26-14-18(25)23(27-22)33-12-8-30-6-10-32-11-7-30/h1-5,9,13-14H,6-8,10-12,15H2
Standard InChI Key: XWOZRFODXUXUNL-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 38 0 0 0 0 0 0 0 0999 V2000
40.9077 -1.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9065 -2.1691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6146 -2.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3242 -2.1686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3214 -1.3460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.6128 -0.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1985 -2.5771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1978 -3.3943 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.5373 -3.8702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7892 -4.6476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6065 -4.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8595 -3.8712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.7654 -3.6166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5147 -2.8388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.6975 -2.8368 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.4431 -3.6135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1031 -4.0953 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0861 -5.3073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7515 -6.0540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.2307 -6.7151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0444 -6.6306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3766 -5.8794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8954 -5.2215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.5251 -7.2914 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.1999 -0.9411 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
43.1891 -5.7917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.6713 -6.4514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.4837 -6.3637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9659 -7.0235 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.7784 -6.9358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6356 -7.7710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.2606 -7.5955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9303 -8.3430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
45.1178 -8.4307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 2 0
17 13 1 0
9 13 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
11 18 1 0
21 24 1 0
1 25 1 0
22 26 1 0
26 27 1 0
27 28 1 0
28 29 1 0
29 30 1 0
29 31 1 0
30 32 1 0
31 34 1 0
32 33 1 0
33 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 468.46Molecular Weight (Monoisotopic): 468.1721AlogP: 3.03#Rotatable Bonds: 8Polar Surface Area: 91.33Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.76CX LogP: 3.67CX LogD: 3.66Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.39Np Likeness Score: -2.03
References 1. Rennie GR, Barden TC, Bernier SG, Carvalho A, Deming R, Germano P, Hudson C, Im GJ, Iyengar RR, Jia L, Jung J, Kim E, Lee TW, Mermerian A, Moore J, Nakai T, Perl NR, Tobin J, Zimmer DP, Renhowe PA.. (2021) Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulator., 40 [PMID:33662540 ] [10.1016/j.bmcl.2021.127886 ]